Palvi Shah

Most-cited papers

1. Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study

   A. Church, M. Beerahee, Jean Brooks, R. Mehta +1 more

   2014BMC Pulmonary Medicine31 citations Open access

   Semantic Scholar

   Save

2. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag

   M. Tarantino, P. Fogarty, Palvi Shah, A. Brainsky

   2015Platelets16 citations

   Semantic Scholar

   Save

3. Dose response of umeclidinium administered once or twice daily in patients with COPD: A pooled analysis of two randomized, double‐blind, placebo‐controlled studies

   J. Donohue, C. Kalberg, Palvi Shah, M. Beerahee +3 more

   2014Journal of clinical pharmacology12 citations

   Semantic Scholar

   Save

4. Umeclidinium (GSK573719) dose response and dosing interval in COPD

   A. Church, M. Beerahee, Jean Brooks, R. Mehta +1 more

   20124 citations

   Semantic Scholar

   Save

5. An Analysis of the Dose Response of Umeclidinium (GSK573719) Administered Once or Twice Daily in Patients With COPD

   A. Church, C. Kalberg, Palvi Shah, M. Beerahee +1 more

   20122 citations

   Semantic Scholar

   Save

6. Time to Splenectomy Failure in Patients with Recurrent or Refractory Chronic Immune Thrombocytopenic Purpura.

   G. Cheng, T. Gernsheimer, H. Olney, J. Bussel +4 more

   20091 citations

   Semantic Scholar

   Save

7. Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD

   M. Beerahee, Jean Brooks, R. Mehta, Palvi Shah +18 more

   20120 citations

   Semantic Scholar

   Save